<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218943</url>
  </required_header>
  <id_info>
    <org_study_id>N-44-2017</org_study_id>
    <nct_id>NCT03218943</nct_id>
  </id_info>
  <brief_title>Physiological Dead Space Measured by Volumetric Capnography in BiPAP and APRV .</brief_title>
  <official_title>Physiological Dead Space Measured by Volumetric Capnography, Is it Different Between the Biphasic Positive Airway Pressure Mode ( BiPAP ) and Airway Pressure Release Ventilation Mode ( APRV ) ? A Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and Rationale :

      Mechanical ventilation is an essential component of the care of patients with respiratory
      failure.Biphasic positive Airway Pressure (BiPAP) and Airway Pressure release ventilation
      (APRV) are relatively new modes of mechanical ventilation which can be used in treatment of
      patients with impaired oxygenation.The effect of using BiPAP and APRV modes on reducing the
      physiological dead space had not been previously investigated. The investigators hypothesize
      that using APRV mode will decrease physiological dead space more than BiPAP mode in the
      mechanically ventilated critically ill patients.

      Objectives :

      To assess the physiological dead space with each mode. To assess lung mechanics during the
      use of the two modes. To assess the effectiveness of ventilation during the use of the two
      modes.

      Study population &amp; Sample size :

      Sixty adult patients more than 18 years old who are mechanically ventilated patients with P/F
      ratio less than 300. This sample size was calculated based on the assumption that APRV will
      decrease dead space by 20% with alpha error 0.05 and power 80%. The mean and Standard
      deviation of the volume of the dead space assessed in a previous study using BIPAP was 40

      Study Design :

      A randomized controlled non-blinded study with cross-over design. In the Trauma and surgical
      ICU at 185-Hospital (Kasr Alainy Hospitals).

      Methods :

      All mechanically ventilated patients in Trauma and surgical ICU at 185-Hospital (Kasr Alainy
      Hospitals) will start on pressure controlled ventilation mode (PCV) with inspiratory pressure
      achieving tidal volume 6-8 ml/kg for 2 hours then they will be randomized into one of the two
      study groups the BIPAP group or the APRV group .

      Possible Risk (s) to study population :

      By adjusting the ventilator parameters properly and continuous monitoring of the patients in
      the study, there will be no risk facing the patients.

      Outcome parameter (s):

      Primary outcome: Physiological dead space will be measured in the two groups after 30
      minutes.

      Secondary outcomes

        -  Physiological dead space after 3 hours.

        -  PO2/FiO2 ratio.

        -  Peak airway and Mean airway pressures.

        -  PCO2 and PH.

        -  Dynamic compliance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All mechanically ventilated patients in Trauma and surgical ICU at 185-Hospital (Kasr Alainy
      Hospitals) will start on pressure controlled ventilation mode (PCV) with inspiratory pressure
      achieving tidal volume 6-8 ml/kg for 2 hours then they will be randomized into : A-group
      (APRV group) &amp; B-group (BiPAP group). which are described later in the 2 arms of the study.

      Measurement tools :

      The following data will be recorded :

        -  Demographic data ( Age , Sex , Weight and Height ).

        -  P/F ratio before inclusion.

        -  All patients then will be connected to Volumetric capnography which is included in the
           metabolic module on General Electric ventilator (Engstrom Carestation, GE Health care,
           USA). and physiological dead space will be recorded after 30 minutes and at the end of
           the 3 hours on each APRV &amp; BiPAP modes .

        -  Peak air way pressure.

        -  Mean airway Pressure. They will be also recorded after

        -  Dynamic Compliance. 30 Minutes and at the end of the

        -  P/F ratio , PH and pCO2. 3 hours On APRV &amp; BiPAP modes.

        -  Minute ventilation.

        -  Blood pressure , Heart rate and central venous pressure will be recorded before
           inclusion . then , they will be also recorded every 2 hours .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 25, 2017</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A randomized controlled study with cross-over design.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physiological dead space</measure>
    <time_frame>after 30 min. on each mode ( APRV and BiPAP )</time_frame>
    <description>percentage of vd/vt ( dead space volume/ Tidal volume ) which is measured by volumetric capnography included in the metabolic module on General Electric ventilator (Engstrom Carestation, GE Health care, USA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiological dead space.</measure>
    <time_frame>after 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>percentage of vd/vt ( dead space volume/ Tidal volume ) which is measured by volumetric capnography included in the metabolic module on General Electric ventilator (Engstrom Carestation, GE Health care, USA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PO2/FiO2 ratio</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>PO2 from ABG / FiO2 set on the ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak airway pressure</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>measured by the ventilator in cmH2O.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean airway pressure</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>measured by the ventilator in cmH2O.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic compliance</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>measured by the ventilator ml/cmH2O</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCO2</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>from ABG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH</measure>
    <time_frame>after 30 min. and 3 hours on each mode ( APRV and BiPAP ).</time_frame>
    <description>from ABG</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ventilation Therapy; Complications</condition>
  <arm_group>
    <arm_group_label>APRV ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They will start on APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours Then, they will return to the initial settings ( PCV ) for 2 hours . then, they will be switched into BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours. Then left for ventilation according to the preference of the physician in charge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BiPAP ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They will start on BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours. Then, they will return to the initial settings ( PCV ) for 2 hours . then, they will be switched into APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours. Then left for ventilation according to the preference of the physician in charge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>APRV ventilation mode</intervention_name>
    <description>They will start on APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours</description>
    <arm_group_label>APRV ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BIPAP ventilation moood</intervention_name>
    <description>start on BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours</description>
    <arm_group_label>BiPAP ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults above 18 years old.

          -  Patients who are recently mechanically ventilated ( within 48 hours ).

          -  Patients with P/F ratio less than 300.

        Exclusion Criteria:

          -  patients with COPD or pneumothorax.

          -  Patients with acute lung injury.

          -  patients with Emphysema and Emphysematous bullae .

          -  patients with broncho-pleural fistula.

          -  patients with severe hemodynamic instability (on IV Noradrenaline &gt; 0.8 mic/kg/min).

          -  patients with cardiomyopathy , and those with stenotic valvular diseases.

          -  Patients with increased intracerebral pressure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Elkahwagy</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesia , intensive care and pain management at kasr Alainy hospitals -faculty of medicine - Cairo Uni. - Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed Elkahwagy</last_name>
    <phone>00201008390999</phone>
    <email>dr.qahwagy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesia , intensive care and pain management -faculty of medicine Cairo Uni.- kasr Alainy Hospitals.</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Elkahwagy</last_name>
      <phone>00201008390999</phone>
      <email>dr.qahwagy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/14635498</url>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/8143712</url>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/2686487</url>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/27334879</url>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/11094503</url>
  </link>
  <reference>
    <citation>Haitsma JJ, Lachmann RA, Lachmann B. Lung protective ventilation in ARDS: role of mediators, PEEP and surfactant. Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):108-18. Review.</citation>
    <PMID>14635498</PMID>
  </reference>
  <reference>
    <citation>HÃ¶rmann C, Baum M, Putensen C, Mutz NJ, Benzer H. Biphasic positive airway pressure (BIPAP)--a new mode of ventilatory support. Eur J Anaesthesiol. 1994 Jan;11(1):37-42. Review.</citation>
    <PMID>8143712</PMID>
  </reference>
  <reference>
    <citation>Baum M, Benzer H, Putensen C, Koller W, Putz G. [Biphasic positive airway pressure (BIPAP)--a new form of augmented ventilation]. Anaesthesist. 1989 Sep;38(9):452-8. German.</citation>
    <PMID>2686487</PMID>
  </reference>
  <reference>
    <citation>Verscheure S, Massion PB, Verschuren F, Damas P, Magder S. Volumetric capnography: lessons from the past and current clinical applications. Crit Care. 2016 Jun 23;20(1):184. doi: 10.1186/s13054-016-1377-3. Review.</citation>
    <PMID>27334879</PMID>
  </reference>
  <reference>
    <citation>Anderson CT, Breen PH. Carbon dioxide kinetics and capnography during critical care. Crit Care. 2000;4(4):207-15. Epub 2000 Jul 12. Review.</citation>
    <PMID>11094503</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2017</study_first_posted>
  <last_update_submitted>August 19, 2017</last_update_submitted>
  <last_update_submitted_qc>August 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed Samir Awad Elkahwagy</investigator_full_name>
    <investigator_title>Principal Investigator ,Dr. Ahmed Samir Elkahwagy</investigator_title>
  </responsible_party>
  <keyword>BiPAP</keyword>
  <keyword>APRV</keyword>
  <keyword>Physiological dead space</keyword>
  <keyword>volumetric capnography</keyword>
  <keyword>ARDS</keyword>
  <keyword>impaired oxygenation</keyword>
  <keyword>ICU</keyword>
  <keyword>Mechanical ventilation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

